Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-09-13
1999-07-27
Campell, Bruce R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 2, 424 932, 424 9321, 935 62, A01N 6300, A01N 3718, A61K 3800, A61K 4800
Patent
active
059290412
ABSTRACT:
The present invention relates generally to methods for preventing and/or treating injury or degeneration of cochlear (and vestibular) hair cells and spiral ganglion neurons (as well as vestibular neurons--Carpa's neurons) by administering glial cell line-derived neurotrophic factor (GDNF). The invention relates more specifically to methods for treating sensorineural hearing loss and vestibular disorders.
REFERENCES:
patent: 4518584 (1985-05-01), Mark et al.
patent: 5106627 (1992-04-01), Aebischer et al.
patent: 5653975 (1997-08-01), Baetge et al.
patent: 5658785 (1997-08-01), Johnson
Malik et al. (1992), `Polyethylene Glycol (PEG)-modified Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) with Conserved Biological Activity`, Exp. Hematol. 20:1028-1035.
Matheson et al. (1995), `The In Vivo Responses of Neonatal Rat Dorsal Root Ganglion Neurons to Neurothrophins and GDNF`, Soc. Neurosci. Abstr. 21:544.
Mullins et al. (1990), `Ophthalmic Preparations`, Remington's Pharmaceutical Sciences, 18th Ed, Ch. 86:1581-1595.
Nadol (1993), `Hearing Loss`, New England J. of Medicine 329:1092-1102.
Oppenheim et al. (1995), `Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF`, Nature 373:344-346.
Pirvola et al. (1992), `Brain-derived neurotrophic factor and neurotrophin 3 mRNAs in the peripheral target fields of developing inner ear ganglia`, Proc. Natl. Acad. Sci. USA 89:9915-9919.
Poulsen et al. (1994), `TGF.beta.2 and TGF.beta.3 Are Potent Survival Factors for Midbrain Dopaminergic Neurons`, Neuron 13:1245-1252.
Schecterson et al. (1994), `Neurotrophin and neurotrophin receptor mRNA expression in developing inner ear`, Hearing Res. 73:92-100.
Spoendlin (1984), `Primary Neurons and Synapses`, Ultrastructural Atlas of the Inner Ear Ch. 6:133-164.
Tresco et al. (1992), `Polymer Encapsulated Neurotransmitter Secreting Cells`, ASAIO 38:17-23.
Trupp et al. (1995), `Peripheral Expression and Biological Activities of GDNF, a New Neurotrophic Factor for Avian and Mammalian Peripheral Neurons`, J. Cell Biol. 130:137-148.
Wheeler et al. (1994), `Expression of BDNF and NT-3 mRNA in hair cells of the organ of Corti: Quantitative analysis in developing rats`, Hearing Res. 73:46-56.
Winn et al. (1991), `Behavioral Recovery following Intrastriatal Implantation of Microencapsulated PC12 Cells`, Exper. Neurol. 113:322-329.
Yan et al. (1992), `Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death`, Nature 360:753-755.
Yan et al. (1995), `In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons`, Nature 373:341-344.
Aebischer et al. (1991), `Long-Term Cross-Species Brain Transplantation of a Polymer-Encapsulated Dopamine-Secreting Cell Line`, Exper. Neurol. 111:269-275.
Apfel et al. (1991), `Nerve Growth Factor Prevents Toxic Neuropathy in Mice`, Ann. Neurol. 29:87-90.
Cunningham and Wells (1989), `High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis`, Science 244:1081-1085.
Ernfors et al. (1995), `Complementary Roles of BDNF and NT-3 in Vestibular Auditory Development`, Neuron 14:1153-1164.
Gao et al. (1995), `Neurotrophin-4/5 Enhances Survival of Cultured Spiral Ganglion Neurons and Protects Them from Cisplatin Neurotoxicity`, J. Neurosci. 15(7):5079-5087.
Hefti (1986), `Nerve Growth Factor Promotes Survival of Septal Cholinergic Neurons After Fimbrial Transections`, Neurosci. 6:2155-2162.
Hefti (1994), `Neurotrophic Factor Therapy for Nervous System Degenerative Diseases`, J. Neurobiol. 25:1418-1435.
Hyman et al. (1991), `BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra`, Nature 350:230-232.
Knusel et al. (1992), `Brain-derived Neurotrophic Factor Administration Protects Basal Forebrain Cholinergic but Not Nigral Deopaminergic Neurons from Degenerative Changes after Axotomy in the Adult Rat Brain`, J. Neurosci. 12(11):4391-4402.
Koliatsos et al. (1993), `Evidence That Brain-Derived Neurotrophic Factor Is a Trophic Factor for Motor Neurons In Vivo`, Neuron 10:359-367.
Korsching (1993), `The Neurotrophic Factor Concept: A Reexamination`, J. Neurosci. 13(7):2739-2748.
Krieglstein et al. (1995), `TGF-.beta. superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP.sup.+ toxicity`, EMBO J. 14:736-742.
Lefebrve et al. (1994), `Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro`, NeuroReport 5:865-868.
Lin et al. (1993), `GDNF: A Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons`, Science 260:1130-1132.
Staecker, et al. (1995) `NT-3 combined with CNTF promotes survival of neurons in modiolus-spiral ganglion explants`, Neuroreport, 6(11):1533-1537.
Zheng, et al. (1995) `Neurotrophin-4/5, Brain-Derived Neurotrophic Factor, and Neurotrophin-3 Promote Survival of Cultured Vestibular Ganglion Neurons and Protect Them against Neurotoxicity of Ototoxins`, J of Neurobiology, 18(3):330-340.
Kelley (1997), `Cellular Commitment and Differentiation in the Cochlea: Potential Advances Using Gene Transfer` Audiol. Neurootol. 2:50-60.
Lindner et al. (1995), `Implantation of Encapsulated Catecholamine and GDNF-Producing Cells in Rats with Unilateral Dopamine Depletions and Parkinsonian Symptoms` Exp. Neuro 132:62-76.
Choi-Lundberg et al. (1997), `Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy` Science 275:838-841.
Raphael et al. (1996), `Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo` Neuro Ltrs 207:137-141.
Weiss et al. (1997), `Viral-Mediated Gene Transfer in the Cochlea` Int. J. Devl Neuroscience 4/5:577-583.
E. Marshall (1995) Science 269:1050-1055.
Ville et al (1995) Targeted Gene Therapy 9:190-199.
Amgen Inc.
Baker Anne-Marie
Campell Bruce R.
Curry Daniel R.
Levy Ron K.
LandOfFree
Method for preventing and treating sensorineural hearing loss an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preventing and treating sensorineural hearing loss an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preventing and treating sensorineural hearing loss an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-878785